Arca
Skip to content
Tools
Tools

INHA: Enoyl-[acyl-carrier-protein] reductase [NADH]

Protein in Mycobacterium tuberculosis that 2 drugs act on.

  • Drugs that act on it: 2
  • Approved: 2
  • In phases 1 to 3: 0
  • Sponsors: 2

Who is on it, and how far along

Every drug ChEMBL records acting on INHA, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 2

Approved2

  • Isoniazid
  • Ethionamide

Phase 30

    Phase 20

      Phase 10

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
        IsoniazidBoxed warningApprovedBristol-Myers SquibbSmall moleculeInhibitorEnoyl-[acyl-carrier-protein] reductase inhibitor67
        EthionamideApprovedPfizerSmall moleculeInhibitorEnoyl-[acyl-carrier-protein] reductase inhibitor5

        Open trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 13 in all, from ClinicalTrials.gov.
        A Clinical Trial to Improve Treatment Outcomes Among Persons With Drug Sensitive Pulmonary TB Treated With 4 or 6 Months of High Dose Rifampicin Containing Regimens With or Without LevofloxacinIsoniazidPhase 3RecruitingTuberculosis Research Centre, IndiaNov 18, 2026
        Ablation Versus Non-ablation Strategies for Non-puerperal Mastitis: A Prospective Real-world Registry StudyIsoniazid—RecruitingSong HongpingOct 26, 2026
        Latent Infection Freshmen Tracking for TuberculosisIsoniazidPhase 4RecruitingAffiliated Hospital of Nantong UniversitySep 10, 2026
        Study of Combinations of Novel Promising Drugs for Pulmonary TuberculosisIsoniazidPhase 2Not yet recruitingTASK Applied ScienceAug 19, 2026
        A Phase I Study Investigating the Local Tolerability and Pharmacokinetics of Isoniazid (INH) Inhalation by Wet Nebulization in Patients With TuberculosisIsoniazidPhase 1RecruitingUniversity Medical Center GroningenJul 16, 2026
        Rifapentine-Based Shorter Regimens for Tuberculosis and TB Infection in KazakhstanIsoniazid—Not yet recruitingPublic Union "Kazakhstan Association of Phthisiopulmonologists"Jun 25, 2026
        Re-evaluating the Duration in Children of TB TreatmentIsoniazidPhase 2Not yet recruitingUniversity of Wisconsin, MadisonJun 18, 2026
        Comparative Trial Between Ainuovirine(ANV)/Lamivudine(3TC)/Tenofovir(TDF) and Efavirenz(EFV)/Lamivudine/Tenofovir RegimensIsoniazidPhase 4Not yet recruitingShanghai Public Health Clinical CenterJun 8, 2026
        Phase 2a Trial of Alpibectir Plus Ethionamide for Tuberculosis MeningitisEthionamidePhase 2Not yet recruitingBioVersys AGJan 20, 2026
        A Study of the Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With EthionamideEthionamidePhase 2RecruitingTASK Applied ScienceDec 27, 2024
        PanACEA - STEP2C -01EthionamidePhase 2RecruitingMichael HoelscherApr 11, 2023
        The Safety and The Efficacy Evaluation of ET-STEM in Patients With Frontotemporal DementiaEthionamidePhase 1Active, not recruitingSamsung Medical CenterApr 7, 2022
        Population Pharmacokinetics of Anti-tuberculosis Drugs in Children With TuberculosisEthionamide—RecruitingBeijing Children's HospitalAug 10, 2018

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL1849, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

        Esc

        Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

        Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.